Skip to main content
Erschienen in: Virchows Archiv 1/2003

01.07.2003 | Original Article

Glomerular cell apoptosis in human lupus nephritis

verfasst von: Hirofumi Makino, Hitoshi Sugiyama, Yasushi Yamasaki, Yohei Maeshima, Jun Wada, Naoki Kashihara

Erschienen in: Virchows Archiv | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

Disturbed apoptosis is proposed to be involved in the pathogenesis of systemic lupus erythematosus. However, the role of renal cell apoptosis in the pathogenesis and progression of human lupus nephritis is still controversial. We have investigated glomerular cell apoptosis and the clinicopathological relationship between apoptosis and immunoserological or histological findings in 22 patients with lupus nephritis using electron microscopy and the TdT-mediated dUTP-biotin nick end labeling (TUNEL) method. Resident glomerular cells as well as infiltrating neutrophils undergoing apoptosis were observed in 12 of 20 patients with lupus nephritis using electron microscopy. TUNEL-positive cells were recognized in 93% of patients with diffuse proliferative lupus nephritis (class IV) in contrast to the 20% of patients with class V. The number of TUNEL-positive cells in glomeruli significantly correlated with the level of immunoserological activity of lupus, such as anti-double-stranded DNA autoantibody and consumption of plasma complement. There was a positive correlation between glomerular cell apoptosis and the degree of proliferation in lupus nephritis. These data suggest that apoptosis is increased, but not decreased in glomeruli from patients with lupus nephritis. The signals that could induce glomerular cell apoptosis in lupus nephritis will need to be identified.
Literatur
1.
Zurück zum Zitat Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D (1987) Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83:877–885PubMed Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D (1987) Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83:877–885PubMed
2.
Zurück zum Zitat Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391PubMed Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391PubMed
3.
Zurück zum Zitat Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695PubMed Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695PubMed
4.
Zurück zum Zitat Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ,Savill J (1994) Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105–2116PubMed Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ,Savill J (1994) Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105–2116PubMed
5.
Zurück zum Zitat Berden JH, Grootscholten C, Jurgen WC, van der Vlag J (2002) Lupus nephritis: a nucleosome waste disposal defect? J Nephrol 15:S1–S10 Berden JH, Grootscholten C, Jurgen WC, van der Vlag J (2002) Lupus nephritis: a nucleosome waste disposal defect? J Nephrol 15:S1–S10
6.
Zurück zum Zitat Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59PubMed Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59PubMed
7.
Zurück zum Zitat Cameron JS, Turner DR, Ogg CS, Williams DG, Lessof MH, Chantler C, Leibowitz S (1979) Systemic lupus with nephritis: a long-term study. QJM 48:1–24 Cameron JS, Turner DR, Ogg CS, Williams DG, Lessof MH, Chantler C, Leibowitz S (1979) Systemic lupus with nephritis: a long-term study. QJM 48:1–24
8.
Zurück zum Zitat Churg J, Sobin LH (1982) Lupus nephritis. In: Churg J, LH Sobin (eds) Renal disease: classification and atlas of glomerular diseases. Igaku-Shoin, Tokyo, pp 127–149 Churg J, Sobin LH (1982) Lupus nephritis. In: Churg J, LH Sobin (eds) Renal disease: classification and atlas of glomerular diseases. Igaku-Shoin, Tokyo, pp 127–149
9.
Zurück zum Zitat Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMed Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL (1999) Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314PubMed
10.
Zurück zum Zitat Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501PubMed Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501PubMed
11.
Zurück zum Zitat Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMed
12.
Zurück zum Zitat Makino H, Gibbons JT, Reddy MK, Kanwar YS (1986) Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane—I. J Clin Invest 77:142–156PubMed Makino H, Gibbons JT, Reddy MK, Kanwar YS (1986) Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane—I. J Clin Invest 77:142–156PubMed
13.
Zurück zum Zitat Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68:45–55PubMed Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68:45–55PubMed
14.
Zurück zum Zitat Makino H, Hayashi Y, Yamasaki Y, Shikata K, Kashihara N, Kira S, Ota Z (1994) Clinical significance of necrosis in lupus nephritis. Intern Med 33:461–465PubMed Makino H, Hayashi Y, Yamasaki Y, Shikata K, Kashihara N, Kira S, Ota Z (1994) Clinical significance of necrosis in lupus nephritis. Intern Med 33:461–465PubMed
15.
Zurück zum Zitat Makino H, Yamasaki Y, Shikata K, Kashihara N, Sugiyama H, Ogura T, Ota Z (1995) Transition of morphologic features in lupus nephritis: does steroid therapy accelerate glomerulosclerosis? Intern Med 34:982–987 Makino H, Yamasaki Y, Shikata K, Kashihara N, Sugiyama H, Ogura T, Ota Z (1995) Transition of morphologic features in lupus nephritis: does steroid therapy accelerate glomerulosclerosis? Intern Med 34:982–987
16.
17.
Zurück zum Zitat Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449–1456PubMed Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449–1456PubMed
18.
19.
Zurück zum Zitat Sato T, van Dixhoorn MG, Heemskerk E, van Es LA, Daha MR (1997) C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells. Clin Exp Immunol 109:510–517PubMed Sato T, van Dixhoorn MG, Heemskerk E, van Es LA, Daha MR (1997) C1q, a subunit of the first component of complement, enhances antibody-mediated apoptosis of cultured rat glomerular mesangial cells. Clin Exp Immunol 109:510–517PubMed
20.
21.
Zurück zum Zitat Savill J, Smith J, Sarraf C, Ren Y, Abbott F, Rees A (1992) Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924–936PubMed Savill J, Smith J, Sarraf C, Ren Y, Abbott F, Rees A (1992) Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924–936PubMed
22.
Zurück zum Zitat Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131–136 Savill J, Fadok V, Henson P, Haslett C (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131–136
23.
Zurück zum Zitat Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR (1998) IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161:494–503PubMed Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR (1998) IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161:494–503PubMed
24.
Zurück zum Zitat Soto H, Mosquera J, Rodriguez-Iturbe B, Henriquez La Roche C, Pinto A (1997) Apoptosis in proliferative glomerulonephritis: decreased apoptosis expression in lupus nephritis. Nephrol Dial Transplant 12:273–280CrossRefPubMed Soto H, Mosquera J, Rodriguez-Iturbe B, Henriquez La Roche C, Pinto A (1997) Apoptosis in proliferative glomerulonephritis: decreased apoptosis expression in lupus nephritis. Nephrol Dial Transplant 12:273–280CrossRefPubMed
25.
Zurück zum Zitat Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A (1996) Apoptosis in glomerular sclerosis. Kidney Int 49:103–111PubMed Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A (1996) Apoptosis in glomerular sclerosis. Kidney Int 49:103–111PubMed
26.
Zurück zum Zitat Sugiyama H, Kashihara N, Onbe T, Yamasaki Y, Wada J, Sekikawa T, Okamoto K, Kanao K, Maeshima Y, Makino H (1997) Bcl-2 expression and apoptosis in nephrotoxic nephritis. Exp Nephrol 5:481–489PubMed Sugiyama H, Kashihara N, Onbe T, Yamasaki Y, Wada J, Sekikawa T, Okamoto K, Kanao K, Maeshima Y, Makino H (1997) Bcl-2 expression and apoptosis in nephrotoxic nephritis. Exp Nephrol 5:481–489PubMed
27.
Zurück zum Zitat Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K (1995) Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 48:1886–1892PubMed Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K (1995) Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 48:1886–1892PubMed
28.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
29.
Zurück zum Zitat Tax WJ, Kramers C, van Bruggen MC, Berden JH (1995) Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 48:666–673PubMed Tax WJ, Kramers C, van Bruggen MC, Berden JH (1995) Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 48:666–673PubMed
30.
Zurück zum Zitat Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462PubMed Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462PubMed
31.
Zurück zum Zitat Yu CL, Huang MH, Tsai CY, Tsai YY, Tsai ST, Sun KH, Han SH, Yu HS (1998) The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells. Scand J Rheumatol 27:54–60CrossRefPubMed Yu CL, Huang MH, Tsai CY, Tsai YY, Tsai ST, Sun KH, Han SH, Yu HS (1998) The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells. Scand J Rheumatol 27:54–60CrossRefPubMed
Metadaten
Titel
Glomerular cell apoptosis in human lupus nephritis
verfasst von
Hirofumi Makino
Hitoshi Sugiyama
Yasushi Yamasaki
Yohei Maeshima
Jun Wada
Naoki Kashihara
Publikationsdatum
01.07.2003
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 1/2003
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-003-0827-x

Weitere Artikel der Ausgabe 1/2003

Virchows Archiv 1/2003 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …